Inapill
PrivateLast Round
Pre Seed
Mar 1, 2024
Company Overview
Inapill is a biotechnology company developing first-in-class, orally available small molecule therapeutics that target immune cell metabolism to treat inflammatory and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inapill Comparables
Compare Inapill with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sitryx | 84% | |
| META Pharmaceuticals Inc. | 82% | |
| Rheos Medicines | 81% | |
Inapill Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Mar 1, 2024 |
Inapill Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| General Inception | Pre Seed |
| California Life Sciences | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2024
Led by General Inception and California Life Sciences.
Inapill Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Inapill's valuation, stock price, and market status.